Omada Health (NASDAQ:OMDA) President Wei-Li Shao Sells 8,866 Shares

Omada Health, Inc. (NASDAQ:OMDA) President Wei-Li Shao sold 8,866 shares of Omada Health stock in a transaction that occurred on Wednesday, August 12th. The shares were sold at an average price of $25.02, for a total value of $221,827.32. Following the sale, the president directly owned 307,372 shares in the company, valued at $7,690,447.44. The trade was a 2.80% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link.

Wei-Li Shao also recently made the following trade(s):

• On Friday, June 12th, Wei-Li Shao sold 4,589 shares of Omada Health stock. The shares were sold at an average price of $17.24, for a total value of $79,114.36.

Omada Health Trading Down 0.7%

Shares of OMDA opened at $23.84 on Thursday. Omada Health, Inc. has a 1 year low of $10.28 and a 1 year high of $26.92. The stock has a 50 day simple moving average of $20.74 and a 200-day simple moving average of $16.38. The stock has a market cap of $1.46 billion, a PE ratio of 476.80 and a beta of 1.73.

Omada Health (NASDAQ:OMDA) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.08 EPS for the quarter, beating the consensus estimate of ($0.02) by $0.10. Omada Health had a return on equity of 2.67% and a net margin of 1.39%.The business had revenue of $87.83 million for the quarter, compared to analyst estimates of $80.93 million. On average, sell-side analysts forecast that Omada Health, Inc. will post -0.01 EPS for the current fiscal year.

More Omada Health News

Here are the key news stories impacting Omada Health this week:

• Positive Sentiment: Q2 earnings beat expectations. Omada reported earnings of $0.08 per share, compared with the consensus estimate of a $0.02 loss. Revenue reached approximately $87.8 million, exceeding estimates of $80.9 million. The results indicate that growth in the company’s digital chronic-care business is increasingly translating into profitability. Omada Health Q2 earnings analysis
• Positive Sentiment: Analysts raised their price targets. Robert W. Baird increased its target from $15 to $25 while maintaining a neutral rating. Other recent targets include $27 from Citizens JMP and $35 from BTIG, supporting a broader consensus “Moderate Buy” rating with an average target near $25.67.
• Positive Sentiment: Institutional interest has expanded. Perceptive Advisors and BlackRock established new positions during the second quarter, while Millennium Management significantly increased its stake. These investments may provide support by signaling growing institutional confidence in Omada’s outlook.
• Neutral Sentiment: Short interest is effectively nonexistent. Reported short interest was zero shares, offering no meaningful short-covering catalyst but also indicating limited bearish positioning.
• Negative Sentiment: Several senior executives sold shares. CEO Sean Duffy sold 21,570 shares across two transactions, CFO Steven Cook sold 16,842 shares, President Wei-Li Shao sold 8,866 shares, and Chief Accounting Officer Craig Gracey sold 1,042 shares. The sales totaled approximately $1.16 million, mostly near $25 per share. Although the transactions may reflect personal liquidity or compensation planning, concentrated selling by top executives can weigh on investor sentiment.
• Negative Sentiment: Valuation leaves little room for disappointment. Omada’s market capitalization is approximately $1.46 billion and its reported price-to-earnings ratio is above 475. With shares near the top of their 52-week range, investors may be taking profits despite the earnings beat, particularly while analysts such as Baird remain neutral.

Institutional Investors Weigh In On Omada Health

A number of hedge funds have recently added to or reduced their stakes in the stock. Quarry LP bought a new position in shares of Omada Health in the fourth quarter worth about $29,000. TD Waterhouse Canada Inc. bought a new stake in shares of Omada Health during the fourth quarter valued at approximately $32,000. Raymond James Financial Inc. bought a new stake in shares of Omada Health during the second quarter valued at approximately $32,000. Inlight Wealth Management LLC acquired a new stake in shares of Omada Health in the fourth quarter valued at approximately $45,000. Finally, Versant Capital Management Inc raised its position in Omada Health by 319.3% in the 2nd quarter. Versant Capital Management Inc now owns 2,998 shares of the company’s stock worth $66,000 after purchasing an additional 2,283 shares during the last quarter.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on OMDA. The Goldman Sachs Group reaffirmed a “buy” rating on shares of Omada Health in a report on Friday, May 8th. Barclays lifted their price target on shares of Omada Health from $20.00 to $25.00 and gave the company an “overweight” rating in a report on Monday, August 3rd. Weiss Ratings upgraded shares of Omada Health from a “sell (e+)” rating to a “sell (d+)” rating in a research report on Tuesday. Needham & Company LLC reaffirmed a “buy” rating and set a $28.00 price objective on shares of Omada Health in a research note on Friday, May 8th. Finally, Citizens Jmp raised their price objective on shares of Omada Health from $21.00 to $27.00 and gave the stock a “market outperform” rating in a report on Monday, July 20th. Eleven equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $25.75.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.